ArticleFrontiers in immunology2026

Case Report: CD20/BCMA bispecific CAR-T therapy for progressive multiple sclerosis.

Zhenfen Ling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.